Putting risk in perspective: an evidence-based approach to selected risks associated with the use of oral contraception (Q34323993)

1 August 2017

1 reference

title

Putting risk in perspective: an evidence-based approach to selected risks associated with the use of oral contraception (English)

1 reference

1 August 2017

1 reference

Murphy PA

1

1 reference

1 August 2017

1 May 2001

1 reference

Journal of Midwifery & Women's Health

1 August 2017

1 reference

1 August 2017

46

1 reference

1 August 2017

190-198

1 reference

1 August 2017

3

1 reference

Evidence-based care. A new paradigm for clinical practice

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Oral contraceptive health benefits: perception versus reality

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Bias versus causality: interpreting recent evidence of oral contraceptive studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Oral contraceptive use and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Myocardial infarction in users of low-dose oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Myocardial infarction and use of low-dose oral contraceptives: a pooled analysis of 2 US studies

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Stroke in users of low-dose oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Use of low-dose oral contraceptives and stroke in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Oral contraceptives and venous thromboembolism: should epidemiologic associations drive clinical decision making?

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

The reduction in risk of ovarian cancer associated with oral-contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Net effect of oral contraceptive use on the risk of cancer in women in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

A case-control study of oral contraceptive use and invasive epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

Unintended Pregnancy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1526-9523%2801%2900113-1

7 January 2021

10.1016/S1526-9523(01)00113-1

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11480751